Here’s how community pharmacies are adapting to COVID-19
As many Australians settle into a new normal of working from home, virtual meetings and social distancing, community pharmacies are finding ways to operate and even innovate in response to the COVID-19 pandemic.
At-home HIV self-testing kits: what pharmacists should know
At-home HIV self-testing kits have been approved for sale in Australia by the Therapeutic Goods Administration (TGA). What should pharmacists be ready to tell...
TGA pulls the plug on popular cold and flu ingredient
The TGA has removed Andrographis from the listed medicines framework. Here’s what pharmacists need to know about affected products, product recalls and patient counselling.
Topical corticosteroids
Topical corticosteroids are used for various dermatological conditions such as eczema and psoriasis.
Learning objectives
After reading this article, pharmacists should be able to:
Describe...
What do pharmacists need to know about nitazenes?
Nitazenes are becoming more common in the Australian illicit drug market, and are linked to an increasing number of overdoses and deaths.
TGA acts to address rising B6 overuse
From mid-2027, the availability of dozens and dozens of complementary medicines containing vitamin B6 will change.













